Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report

Intravitreally injected ranibizumab versus photodynamic therapy for CNV secondary to choroidal osteoma: a 7-year follow-up case report

Bibliographic Details
Main Authors:	Li-Yuan Rong, Li Ran, Shi-Ying Li, Xiao-Hong Meng, Yan-Ling Long, Hai-Wei Xu
Format:	Article
Language:	English
Published:	Press of International Journal of Ophthalmology (IJO PRESS) 2021-06-01
Series:	International Journal of Ophthalmology
Online Access:	http://ies.ijo.cn/en_publish/2021/6/20210622.pdf

Similar Items

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
by: Sidra Zafar, et al.
Published: (2016-12-01)

Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
by: Rodney J Morris, et al.
Published: (2011-01-01)

Effect of photodynamic therapy combined with intravitreal ranibizumab injection on circumscribed choroidal hemangioma
by: Yu-Shun Xue, et al.
Published: (2017-02-01)

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma
by: Zenith H.Y. Wu, et al.
Published: (2012-06-01)

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
by: Almila Sarıgül Sezenöz, et al.
Published: (2017-08-01)

Therapeutic effect of photodynamic therapy and intravitreal injection with ranibizumab for choroidal neovascularization of pathologic myopia
by: Cong Zhang, et al.
Published: (2014-07-01)

Efficacy of intravitreal Ranibizumab injection for choroidal neovascularization secondary to pathologic myopia
by: Li-Hong Cui, et al.
Published: (2016-03-01)

Long-term results of intravitreal ranibizumab for osteoma-related choroidal neovascularization in a child
by: Aditi Gupta, et al.
Published: (2014-01-01)

Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization
by: Ellabban AA, et al.
Published: (2012-05-01)

Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Kikushima Wataru, et al.
Published: (2020-01-01)

Photodynamic Therapy and Bevacizumab Combination for Polypoidal Choroidal Vasculopathy Refractory to Intravitreal Ranibizumab
by: Zeynep Alkin, et al.
Published: (2016-12-01)

Successful management of choroidal neovascular membrane secondary to choroidal osteoma with intravitreal bevacizumab
by: Brijesh Takkar, et al.
Published: (2017-04-01)

Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy.
by: Wataru Kikushima, et al.
Published: (2020-01-01)

Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10]
by: Sidra Zafar, et al.
Published: (2017-04-01)

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization Secondary to Endogenous Endophthalmitis
by: Shwu-Jiuan Sheu
Published: (2009-11-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Neeraj Pandey, et al.
Published: (2013-01-01)

Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
by: Nikunj J Shah, et al.
Published: (2011-01-01)

Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Yoshikawa T, et al.
Published: (2015-03-01)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01)

Intravitreal bevacizumab for management of choroidal osteoma without choroidal neovascularization
by: Farhad Fazel Najafabadi, et al.
Published: (2015-01-01)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
by: Karagiannis D, et al.
Published: (2017-06-01)

Intravitreal aflibercept for choroidal neovascularization secondary to angioid streaks in a non-responder to intravitreal ranibizumab
by: Makri OE, et al.
Published: (2018-09-01)

Choroidal osteoma with choroidal neovascular membrane: Successful treatment with intravitreal bevacizumab
by: Neeraj Pandey, et al.
Published: (2010-09-01)

Single intravitreal ranibizumab for myopic choroidal neovascularization
by: Shatriah I, et al.
Published: (2011-08-01)

Effect of intravitreal injection of Ranibizumab on choroid in patients with severe NPDR with macular edema
by: Fu-Qin Du, et al.
Published: (2017-11-01)

The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
by: William J. Carroll, et al.
Published: (2020-07-01)

Comparison of the effects of photodynamic therapy, intravitreal ranibizumab and combination for polypoidal choroidal vasculopathy under 1 + PRN regimen
by: Kunbei Lai, et al.
Published: (2018-06-01)

Comparison of Two-Year Outcome of Photodynamic Therapy in Combination with Intravitreal Aflibercept or Ranibizumab for Polypoidal Choroidal Vasculopathy
by: Hsin-Yu Weng, et al.
Published: (2021-01-01)

One-year results of intravitreal ranibizumab combined with reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy
by: Sakurai M, et al.
Published: (2014-01-01)

Role of optical coherence tomography angiography in myopic choroidal neovascularization after intravitreal injections of Ranibizumab
by: Meng Cai, et al.
Published: (2017-10-01)

Long-term success of intravitreal bevacizumab for choroidal neovascularization associated with choroidal osteoma
by: Kubota-Taniai M, et al.
Published: (2011-07-01)

Effects of three consecutive monthly intravitreal injection of ranibizumab for polypoidal choroidal vasculopathy in Korea
by: Young Gun Park, et al.
Published: (2015-04-01)

Electrophysiologic changes after intravitreal ranibizumab injection for the treatment of choroidal neovascular membrane (CNVM)
by: Bhurayanontachai P, et al.
Published: (2011-05-01)

Long-Term Follow-Up of Polypoidal Choroidal Vasculopathy Secondary to Angioid Streaks Treated by Intravitreal Aflibercept and Ranibizumab
by: James G. Wong, et al.
Published: (2017-04-01)

Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia
by: Pukhraj Rishi, et al.
Published: (2011-01-01)

Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup
by: Maribel Fernández, et al.
Published: (2012-01-01)

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
by: Jay Kumar Chhablani
Published: (2010-01-01)

Effect of Intravitreal Ranibizumab in the Treatment of Peripapillary Choroidal Neovascularisation
by: Hassan Hamoudi, et al.
Published: (2011-01-01)

Intravitreal injection of Ranibizumab combined with laser photocoagulation for macular edema secondary to BRVO
by: Guo-Ping Wang, et al.
Published: (2018-02-01)

RETRACTED: Choroidal osteoma with CNVM – Successful treatment with intravitreal Bevacizumab
by: Guruprasad S. Ayachit, MS, et al.
Published: (2011-04-01)